Vitamin B12 interactions

Vitamin B 12 Deficiency In metformin clinical trials of 29 week duration, a decrease to subnormal levels of previously normal serum vitamin B 12 levels was observed in approximately 7% of patients. (Alogliptin and metformin label, Warnings and precautions)

Vitamin B12 Deficiency In controlled clinical trials of metformin of 29-week duration, a decrease to subnormal levels of previously normal serum vitamin B 12 levels, without clinical manifestations, was observed in approximately 7% of patients. (Dapagliflozin and metformin label, Warnings and precautions)

This diagnosis should be considered if clinical symptoms consistent with cyanocobalamin deficiency are observed in patients treated with DEXILANT. (Dexlansoprazole label, Warnings and precautions)

Vitamin B 12 Deficiency In metformin HCl clinical trials of 29-week duration, a decrease to subnormal levels of previously normal serum vitamin B 12 levels was observed in approximately 7% of metformin-treated patients. (Empagliflozin and metformin label, Warnings and precautions)

This diagnosis should be considered if clinical symptoms consistent with cyanocobalamin deficiency are observed. (Esomeprazole label, Warnings and precautions)

Vitamin B12 Levels: In controlled clinical trials with metformin of 29 weeks duration, a decrease to subnormal levels of previously normal serum vitamin B 12 , without clinical manifestations, was observed in approximately 7% of patients. (Glipizide and metformin label, Precautions)

Vitamin B12 Deficiency In clinical studies of 29-week duration with metformin HCl tablets, a decrease to subnormal levels of previously normal serum vitamin B 12 levels, was observed in approximately 7% of patients. (Glyburide and metformin label, Warnings and precautions)

This diagnosis should be considered if clinical symptoms consistent with cyanocobalamin deficiency are observed in patients treated with PREVACID or PREVACID SoluTab. (Lansoprazole label, Warnings and precautions)

Vitamin B 12 Deficiency In metformin clinical trials of 29-week duration, a decrease to subnormal levels of previously normal serum vitamin B 12 levels was observed in approximately 7% of metformin-treated patients. (Linagliptin and metformin label, Warnings and precautions)

Monitor hematological parameters annually and vitamin B 12 at 2 to 3 year intervals and manage any abnormalities. (Metformin label, Warnings and precautions)

This diagnosis should be considered if clinical symptoms consistent with cyanocobalamin deficiency are observed. (Naproxen and esomeprazole label, Warnings and precautions)

Change in vitamin B12 levels: Monitor vitamin B 12 levels during treatment ( 5.6 ). (Octreotide label, Warnings and precautions)

This diagnosis should be considered if clinical symptoms consistent with cyanocobalamin deficiency are observed in patients treated with PRILOSEC. (Omeprazole label, Warnings and precautions)

This diagnosis should be considered if clinical symptoms consistent with cyanocobalamin deficiency are observed in patients treated with KONVOMEP. (Omeprazole and sodium bicarbonate label, Warnings and precautions)

Initiate supplementation with oral folic acid and intramuscular vitamin B 12 to reduce the severity of hematologic and gastrointestinal toxicity of PEMFEXY. (Pemetrexed label, Warnings and precautions)

Monitor hematologic parameters annually and vitamin B 12 at 2 to 3 year intervals and manage any abnormalities. (Pioglitazone and metformin label, Warnings and precautions)

Administer vitamin B 12 and instruct patients to take folic acid to reduce the risk of treatment-related myelosuppression [see Dosage and Administration ( 2.1 )]. (Pralatrexate label, Warnings and precautions)

This diagnosis should be considered if clinical symptoms consistent with cyanocobalamin deficiency are observed in patients treated with ACIPHEX. (Rabeprazole label, Warnings and precautions)

Vitamin B 12 Deficiency In controlled clinical trials of metformin of 29-week duration, a decrease to subnormal levels of previously normal serum vitamin B 12 levels, without clinical manifestations, was observed in approximately 7% of patients. (Saxagliptin and metformin label, Warnings and precautions)

Vitamin B 12 Deficiency In controlled clinical trials of metformin of 29 weeks duration, a decrease to subnormal levels of previously normal serum vitamin B 12 levels was observed in approximately 7% of patients. (Sitagliptin and metformin label, Warnings and precautions)

Long-term acid-reducing therapy interferes with B12 absorption from food and can lead to deficiency. (NIH Office of Dietary Supplements, Vitamin B12)

Long-term acid-reducing therapy interferes with B12 absorption from food and can lead to deficiency. (NIH Office of Dietary Supplements, Vitamin B12)

The morphologic change resembles pernicious anemia, but is not related to vitamin B12 or folic acid deficiency. (Hydroxyurea label, Warnings and precautions)

Long-term acid-reducing therapy interferes with B12 absorption from food and can lead to deficiency. (NIH Office of Dietary Supplements, Vitamin B12)

Oral neomycin inhibits the gastrointestinal absorption of penicillin V, oral vitamin B-12, methotrexate and 5-fluorouracil. (Neomycin label, Drug interactions)

Long-term acid-reducing therapy interferes with B12 absorption from food and can lead to deficiency. (NIH Office of Dietary Supplements, Vitamin B12)

Long-term acid-reducing therapy interferes with B12 absorption from food and can lead to deficiency. (NIH Office of Dietary Supplements, Vitamin B12)

Long-term acid-reducing therapy interferes with B12 absorption from food and can lead to deficiency. (NIH Office of Dietary Supplements, Vitamin B12)

Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B 12 . (Rifapentine label, Drug interactions)